X Financial XYF Q1 2025 Earnings Call Transcript
DATE
Tuesday, May 20, 2025, at 7:30 a.m. EDT
CALL PARTICIPANTS
Chief Executive Officer — Kent Li
Chief Financial Officer — Frank Fuya Zheng
President — Noah Kauffman
Investor Relations — Victoria Yu
Need a quote from one of our analysts? Email pr@fool.com
TAKEAWAYS
Loan Originations: Facilitated RMB 35.15 billion in new loans, up 8.8% sequentially and 63.4% year over year.
Total Revenue: Reached RMB 1.94 billion, a 13.4% increase from Q4 2024 and over 60% year over year.
Asset Quality: 31 to 60-day delinquency rate improved to 1.25% (from 1.61%); 91 to 180-day delinquency rate declined to 2.7% (from 4.7%).
Total Loan Outstanding Balance: RMB 58.4 billion, excluding loans over 60 days delinquent, up over 33% year over year.
Loans Facilitated: Over 3.14 million processed, with an average loan amount of RMB 11,181.
Income from Operations: RMB 573 million, up 52% year over year, reflecting improved operational leverage and expense management.
Non-GAAP Adjusted Net Income: Reached RMB 467 million, a 44.9% increase year over year.
Basic Earnings per ADS: USD 1.50, up approximately 45.6% year over year.
Return on Equity: Increased to 25.5%, up 1.4 percentage points year over year and 3.2 percentage points sequentially.
Share Repurchase Program: New buyback plan authorized for up to $100 million of Class A shares and ADS, effective January 1, 2025 to November 30, 2026, in addition to $15.9 million remaining from a previous plan.
Q2 2025 Outlook: Management expects facilitated and originated loan amounts to range from RMB 37.5 billion to RMB 39.5 billion.
Regulatory Environment: Management described the recent National Financial Regulatory Administration notice as reinforcing "responsible credit assets and financial stability" and committed to regulatory compliance.
SUMMARY
X Financial (NYSE:XYF) delivered double-digit sequential and year-over-year growth in loan originations and revenue, which management attributed to rising borrower demand and disciplined risk management. The company reported substantial improvements in adjusted net income, operational leverage, and return on equity. Despite seasonally negative effects, delinquency rates declined across key periods, with management citing enhancements to technology, underwriting, and customer engagement. Management indicated confidence in the near-term growth outlook and described increased regulatory oversight as a constructive industry development.
Chief Financial Officer Zheng said, "We have recently authorized a new share repurchase plan allowing us to buy back up to $100 million worth of our Class A shares and ADS."
Chief Executive Officer Li stated, "our delinquency rate will still have some uptick, but those upticks will be more than offset by our overall scale. That basically means that our profit will continue to grow despite minor increases in delinquency rates."
Management reiterated that preparation for a new regulation is underway and indicated the company remains "fully compliant with the new regulation before the October 1st deadline."
The company signaled it "will keep the same pace in the acquisition effort in the second quarter" and aims to achieve 30% volume growth this year, pending any regulatory impacts in the fourth quarter.
INDUSTRY GLOSSARY
ADS: American depositary share, a U.S.-traded equity share representing a specified number of shares in a foreign company.
Delinquency Rate (31-60/91-180 Day): The percentage of outstanding loans that are 31 to 60 days, or 91 to 180 days, past due but not yet written off, used as an indicator of portfolio credit quality.
Loan Origination: The process by which a lender approves and funds new loans for borrowers, relevant here as a measure of business activity volume for X Financial's marketplace.
Full Conference Call Transcript
Kent Li: Thank you, Victoria, and hello, everyone. We are pleased with our 2025 headwinds. In the first quarter, we facilitated RMB 35.15 billion in loans, an 8.8% sequential increase and 63.4% growth year over year. It was one of our strongest quarters for origination, reflecting solid borrower demand and continued progress in risk management. Our team remained focused on expanding opportunities through both new partnerships and existing relationships, enhancing our technology platform and underwriting models to support profitability and scalability. Balancing growth and risk as we broaden access to qualified borrowers, we are also working to improve the borrower experience by delivering faster decisions, simplifying application processes, and enhancing transparency.
In parallel, we continue to strengthen platform reliability and support tools to help customers make informed borrowing decisions and manage repayment with confidence. Despite the typical seasonal impact from Chinese New Year, we achieved sequential growth in both loan volume and revenue. Total revenue reached RMB 1.94 billion, up 13.4% from Q4 and over 60% year over year. These results reflected steady progress in growing the platform responsibly. Operational and credit quality update. We also made continued progress on asset quality. As of March 31st, our 31 to 60-day delinquency rate was 1.25%, compared to 1.61% a year ago, reflecting a 22% improvement year over year.
The 91 to 180-day delinquency rate was 2.7%, down from 4.7% in Q1 2024, a 37% reduction year over year. These improvements reflect disciplined borrower screening and underwriting practices. We have also continued to enhance borrower engagement and repayment behavior through timely communication and tailored repayment assistance programs. These initiatives have contributed meaningfully to our risk management outcomes and supported further portfolio stability. Now I will turn the call to Noah to go over some key Q1 metrics and highlights.
Noah Kauffman: Thank you, Kent. Hello, everyone. It's a pleasure to speak with you today. Let me share several highlights from our Q1 operational and financial performance. On the operational metrics, we facilitated approximately RMB 35.15 billion in loan originations, marking a 63.4% year-over-year increase. Our total loan outstanding balance, excluding loans over 60 days delinquent, reached RMB 58.4 billion, growing by more than 33% from Q1 2024. We facilitated over 3.14 million loans with an average loan amount of RMB 11,181. On the financial highlights, total revenue grew to RMB 1.94 billion, up 13.4% sequentially and 60.4% year over year, primarily driven by higher borrow volumes and originations.
Our income from operations expanded substantially, reaching RMB 573 million, up 52% year over year. This demonstrates our improved operational leverage and disciplined expense management. Our average funding costs improved year over year, supported by a more optimized funding structure and sustained commitment from our core institutional partners. This reflects the strength of our platform and deepening trust within our funding network. With these metrics, we continue to see notable gains in operational efficiency and market positioning. I'll now hand the call over to Frank to walk through the financials, discuss capital allocation priorities, provide regulatory insights, and outline our growth outlook for 2025.
Frank Fuya Zheng: Thank you, Noah. It's great to speak with everyone today. I will provide additional insights into our profitability metrics, liquidity, and strategic plans for capital allocation. Non-GAAP adjusted net income for Q1 reached RMB 467 million, an increase of 44.9% year over year, reflecting sustained earnings. Basic earnings per ADS improved significantly to USD 1.50, approximately a 45.6% year-over-year increase, underscoring enhanced profitability per share. Return on equity increased to 25.5%, widening 1.4 percentage points year over year and 3.2 percentage points sequentially, reflecting our sustained financial discipline and growing operational efficiency. Our liquidity remains strong, positioning us well to support ongoing operations, investments, and capital returns. Share repurchase plan.
We have recently authorized a new share repurchase plan allowing us to buy back up to $100 million worth of our Class A shares and ADS. This authorization will be in effect for an 18-month period running from January 1, 2025, to November 30, 2026. This new authorization comes in addition to our existing repurchase plan approved last December, which still has approximately $15.9 million remaining. Regulatory environment update. The regulatory environment in China remains dynamic, and we remain fully committed to compliance and alignment with the overall policy direction. The recent notice from the National Financial Regulatory Administration affirms the current trajectory with a clear focus on responsible credit assets and financial stability.
We see increased oversight as a positive step that supports long-term industry development and reflects growing recognition of our role. While evolving rules introduce high compliance requirements, they also create space for innovation and more sustainable growth. We continue to engage proactively with regulatory bodies and remain focused on responsible execution within the evolving framework. 2025 growth outlook. Based on current trends, X Financial expects the total loan amount facilitated and originated in the second quarter of 2025 to be in the range of RMB 37.5 billion to RMB 39.5 billion, reflecting continued strong demand in the first quarter. With that, I will pass the call back to our President, Kent Li, for closing remarks.
Kent Li: Thank you, Frank. As we progress through 2025, we remain confident in our strategic direction, grounded in strong underwriting, disciplined risk management, and ongoing operational improvement. With a solid financial foundation and a clear focus on long-term value creation, we are well-positioned for sustainable and profitable growth. Thank you.
Operator: We will now begin the question and answer session. To ask a question, you may press star then one on your touch-tone phone. If you are using a speakerphone, please pick up your handset before pressing the keys. If at any time your question has been addressed and you would like to withdraw your question, you may do so. The first question today comes from Kenning Zhao with Norton Andrews. Please go ahead.
Kenning Zhao: Hi. I'm Kenning from Norton Andrews. Congratulations, and thank you for the great performance in the first quarter. Well, my first question is there's strong growth in your business, both in new loan origination and active users. You mentioned there will be further growth. I wonder if that means you like the current macroeconomic environment and the loan market? And, well, it's not big, but the delinquency rate has also ticked up a little bit compared to the end of last year. If the loan volumes continue to grow, should we expect further increases in the delinquency rate? And, oh, can I have a second question?
Can we get this first question answered first, and then you can ask me the next one?
Kent Li: Of course. Thank you. Responding to your, I think you mentioned several questions in your comments. So let's focus on them one by one. The first one, how we view the current environment. I think our company has never tried to grow our portfolio for the sake of growth. So we are always trying to manage our portfolio based on our assessment of the future environment. That being said, I think right now, based on our historic trend and our analysis, the overall environment is still good for portfolio growth. That is why we are still focused on growth at this moment.
Another thing is that since the second half of last year, we have invested a lot in acquiring new customers. So as these customers mature in our portfolio, we are able to offer them better lines and better products, so they stick with us longer. That is also the best foundation for our growth. In terms of the delinquency rate, I think the reason you see an uptick from the lower level we achieved somewhat last year is that I would say that probably was the bottom part of our delinquency rate. So even with this uptick, I think our delinquency rate with regard to our portfolio is still very healthy. So we are not particularly concerned about that.
And going forward, we do expect that our delinquency rate will still have some uptick, but those upticks will be more than offset by our overall scale. That basically means that our profit will not be impacted by a certain frequency.
Frank Fuya Zheng: Let me add also regarding the delinquency rate. That number is actually as a risk profile situation from last quarter to Q1 is actually stable. And the number is a little bit skewed, and if you take another look, if you look at our Q1 income statement under the operation expense cost expenses, the first one is automation and services. It's basically operation expenses. The second one is the marketing acquisition, customer acquisition. And the third one is general and administration cost. So those are the three general costs. But the rest, like provision this way and provision that way, if you add up together, this is all risk-related cost.
If you add up this quarter, Q1, and you add up Q4 last quarter, all the provisions together, you will find the Q1 provision is about RMB 60 million less than last quarter. But the amount is RMB 60 million actually, because this RMB 57 million is related to our own insurance business, which means because our own insurance business, the revenue you book in one period and the cost you book the whole thing together in one time. Because last quarter, Q4, they did more, well, you know, first the guarantee company did more business so they have more of that.
So if you take out this RMB 57 million, actually, the cost apple to apple, the cost related to, you know, you take out all the, you know, the risk related to the guarantee business, actually, we have a, like, RMB 3-4 million less cost on Q1 compared with Q4. So overall, the conclusion is, you know, the risk situation remains basically the same. Not much better, not much worse. That's the thing. But having said that, we all expect because this regulatory development will be coming in October, we will prepare and there will be costs because of that, there may be some uptick, you know, cost risk situation with some uptick down the road, but not in Q1.
Not in Q2. We haven't found this situation change much at all. That's why we continue to invest a lot in customer acquisition also.
Kenning Zhao: Thank you for the detailed answer. Well, my second question is about the repurchase. You haven't repurchased any shares in the first quarter, but you have approved another share repurchase program. Just wondering if you repurchased any, like, during April's market volatility, and should we expect you to continue the aggressive stock buybacks as you did last year? Thank you.
Frank Fuya Zheng: Yes. Because Q1 has no open window, so we usually do the buyback during the open window from the old shareholders. Right now, I mean, the incoming open window, we pretty much show, you know, the remaining, almost RMB 60 million is locked, it will be used up in the coming open window, and we will very likely kick into the buyback during the, you know, down window period also. So that's why we have this newly authorized RMB 100 million to cover that. I hope it answers your question.
Kenning Zhao: Yes, sir. Thank you very much, and thank you again for the wonderful call.
Operator: The next question comes from Alex Ye with UBS. Please go ahead.
Alex Ye: Hi. Good evening, management. Thanks for taking my question. It's Alex from UBS. So I have two questions, if I may. So the first one is regarding your loan growth guidance for the next quarter. Is it still going to be a bit of a good growth? Just wondering, what's driving the growth behind and how do you see, you know, the underlying loan application or credit demand in the last two months in April or May? Have you seen any suffering trend given a lot of the noise on the macro front? And the second question is a bit on your funding supply.
So given, you know, there has been this new regulatory announcement since April, I'm wondering, have you heard any feedback from your funding partners with regard to their attitude towards this loan pricing, which is going above 24%? And then do you see anything we need to adjust in our current purchase order to ensure that we're more compliant? Thank you.
Kent Li: Okay. I'll first answer the first question about the growth. As I mentioned to the last investor, our growth has always been based on our assessment of the upcoming risk environment. So at this moment, I think that the way we grow our portfolio has always been acquiring new customers, getting the customers on board, and gradually introducing them to better products, which largely means lower fees and higher lines. Our growth has largely grown from this strategy. So you asked about April or May or June. Our growth path has always been like that. In terms of our funding institutional partners, right now, we are in very close conversation with them about the upcoming changes.
And at this moment, what I can say is that we expect there will be changes. We are going to make some adjustments, but I don't see our company has always been confident we will be fully compliant with the new regulation before the October 1st deadline. So we are not particularly concerned about that. That being said, any new regulation will always bring some small shocks to the industry. So we do expect that there will be some shocks in our industry. It's just that I think our company is in a very good position to take those shocks.
So our growth, I think our growth prospect will not be changed based on whatever we are providing to the investors.
Frank Fuya Zheng: Hi, Alex. First of all, welcome to our earnings call. Welcome. Regarding the, let me just basically ask the same question again. And I think we really took advantage of the good risk environment since the second half of last year. So our run rate is, you know, at the end of last year, it's already pretty high, and you saw that we spent very aggressively in acquisition in Q1, and we will keep the same pace in the acquisition effort in the second quarter. So based on our current forecast, we look to Q2 this year, we are ahead of, you know, 30% the gross volume growth for this year.
But we are not, you know, not have no intention to increase the forecast anytime soon because we will, you know, see when in Q3, you know, what's the effect, you know, the regulatory policy impact on the industry. So the YCAA, you know, they look at the insertion regarding Q4 volume, and that's what I'm trying to say. And so overall, I think we are confident to achieve 30% volume growth for this year. But other than that, maybe not more, it's all because Q4 volume is kind of in limbo right now.
Regarding the preparation for the new regulatory, possible regulatory impact, we do some, you know, talking to the people and, you know, talking to the regulatory mostly our institutional partners, and with some regulatory authorities. And we are preparing some, you know, technology-wise, you know, if the deal there's no new policy can come down, and we can accommodate it very quickly, efficiently, you know, from technology operation-wise. Other than that, we, you know, like anybody else, we don't know much of what's going to come down. Thank you.
Alex Ye: Understood. Thank you very much.
Operator: This concludes our question-and-answer session. I would like to turn the conference back over to Victoria Yu for any closing remarks.
Victoria Yu: Thank you, everyone, for joining us today. If you have additional questions, please reach out to our Investor Relations team directly. We appreciate your interest and look forward to speaking with you again soon.
Operator: Thank you. The conference is now concluded. Thank you for attending today's presentation. You may now disconnect.
Where to invest $1,000 right now
When our analyst team has a stock tip, it can pay to listen. After all, Stock Advisor's total average return is 975%* — a market-crushing outperformance compared to 172% for the S&P 500.
They just revealed what they believe are the 10 best stocks for investors to buy right now, available when you join Stock Advisor.
*Stock Advisor returns as of May 19, 2025
This article is a transcript of this conference call produced for The Motley Fool. While we strive for our Foolish Best, there may be errors, omissions, or inaccuracies in this transcript. Parts of this article were created using Large Language Models (LLMs) based on The Motley Fool's insights and investing approach. It has been reviewed by our AI quality control systems. Since LLMs cannot (currently) own stocks, it has no positions in any of the stocks mentioned. As with all our articles, The Motley Fool does not assume any responsibility for your use of this content, and we strongly encourage you to do your own research, including listening to the call yourself and reading the company's SEC filings. Please see our Terms and Conditions for additional details, including our Obligatory Capitalized Disclaimers of Liability.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
2 hours ago
- Globe and Mail
2 Top Artificial Intelligence Stocks to Buy in June
Artificial intelligence (AI) investing is still a major theme in the market. Although some AI hyperscalers have had success rolling out AI models, they aren't making a ton of money from it yet. As a result, I think investors are better off buying shares of the companies benefiting from this spending. This makes shares of companies like Nvidia (NASDAQ: NVDA) and Taiwan Semiconductor (NYSE: TSM) excellent investments right now, and I think they are top AI stocks to buy with a little bit of June remaining. 1. Nvidia There's an old saying: History doesn't repeat itself, but it often rhymes. Applying this wisdom to the AI arms race makes it easy to see a parallel: the gold rush. During the gold rush, only a few prospectors struck gold and got rich, while many of them lost everything. On the flip side, those who sold pickaxes and shovels to the prospectors made a ton of money. That gives rise to the investment description of "picks and shovels," which perfectly describes Nvidia and Taiwan Semiconductor. Nvidia makes graphics processing units (GPUs) that excel at processing workloads requiring immense computing power. A GPU is different from a traditional CPU because it can process multiple calculations in parallel. Combining this attribute with the ability to connect thousands of GPUs together in clusters allows AI hyperscalers to create jaw-dropping computing capacity used to train and run AI models. Nvidia has an iron grip on the data center market, with most estimates stating that Nvidia has a 90% or greater market share in the data center GPU space. This dominance has allowed Nvidia's stock to prosper, as its revenue has dramatically risen since the start of 2023. NVDA Revenue (TTM) data by YCharts Nvidia is far from done growing. It posted 69% revenue growth in Q1 and projects 50% in Q2. With Nvidia's clients announcing record data center spending for this year, it's no surprise that there's a ton of upside left. As a result, I think it's still one of the best AI stocks to own moving forward. 2. Taiwan Semiconductor Nvidia doesn't make the chips that go into its GPUs; that's done by Taiwan Semiconductor. Alongside Nvidia, Taiwan Semi also has several other notable names in the AI arms race as clients, as well as consumer electronics customers like Apple. If you've got a device that would be considered advanced technology, chances are there's a chip produced by Taiwan Semiconductor inside of it. Taiwan Semi is also expanding from its home base in Taiwan to the U.S., Japan, and Germany, reducing the single point of failure risk by having all manufacturing based in Taiwan. Taiwan is always at risk of war with mainland China, which could disrupt the global economy should action occur. However, a takeover would likely trigger the rest of the stock market to sell off heavily. As a result, I think investors overstate the risk of investing in a Taiwan-based company. There's a ton to like about TSMC as an investment, but its growth is near the top. Management projects that Taiwan Semi's AI-related revenue will increase at a 45% compounded annual growth rate (CAGR) over the next five years, with total revenue increasing at nearly a 20% CAGR. That's market-crushing growth, but the stock trades at nearly the same multiple as the broader market, as measured by the S&P 500 (SNPINDEX: ^GSPC). TSM PE Ratio (Forward) data by YCharts At 22.8 times forward earnings, its valuation is almost the same as the S&P 500's 22.9 times forward earnings. This reasonable valuation, combined with above-average growth, makes Taiwan Semiconductor a no-brainer buy today. Investors can confidently take a position here and expect solid returns over the next five years. Should you invest $1,000 in Nvidia right now? Before you buy stock in Nvidia, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Nvidia wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $664,089!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $881,731!* Now, it's worth noting Stock Advisor 's total average return is994% — a market-crushing outperformance compared to172%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of June 9, 2025
Globe and Mail
3 hours ago
- Globe and Mail
10 Reasons to Buy and Hold This Semiconductor Stock Forever
Taiwan Semiconductor Manufacturing (NYSE: TSM) is one of the most valuable companies in the world at a market cap of $1.1 trillion, but it doesn't get the same level of attention that other big tech stocks get like Nvidia or Microsoft do. Still, TSMC's competitive advantages can go toe to toe with any other stock, whether it's in the "Magnificent Seven" or not. On that note, let's take a look at 10 reasons to buy and hold this stock forever. 1. It has dominant market share TSMC is the clear leader in semiconductor manufacturing with roughly 67% market share, and an even higher share of advanced chips, estimated at roughly 90%. With that level of market share, TSMC has pricing power, and its customers have limited alternatives. The company has gained that market share over time, and it's unlikely to erode anytime soon. 2. Demand for semiconductors will continue to grow TSMC is in a great competitive position not just because of its dominant market share, but it's also benefiting from tremendous in its industry due to the growth of artificial intelligence (AI) and technology more broadly. That's a major reason why revenue jumped 42% in the first quarter, and future innovations should continue to drive chip demand. 3. It pioneered the contract foundry model TSMC dominates the chip foundry industry in part because it was the first company to employ the third-party foundry model when it was founded in 1987. Over the years, that model has prevailed over the traditional integrated model. 4. It has top-level customers TSMC's collection of customers helps show why the company is so dominant. Among its top customers are Apple, Nvidia, AMD, and Broadcom, cutting-edge chip-design companies and some of the most innovative companies in technology. 5. It has a huge profit margins Profit margin is one of the clearest indicators of competitive advantage, and TSMC shines in that category. In the first quarter, the company reported an operating margin of 49%, showing it has pricing power and economies of scale. 6. It's getting government subsidies TSMC is not only a dominant company in its own right, but its services are in such high demand as semiconductors are crucial for the global economy. As part of the CHIPS Act, TSMC is receiving $6.6 billion in subsidies, and it's received $2 billion from the Chinese and Japanese governments in recent years. 7. It's historically undervalued Considering its growth rate and competitive advantage, TSMC has been historically undervalued, and that seems to be the case today as it trades at a price-to-earnings ratio of 25, on par with the S&P 500. 8. It has a technological advantage TSMC dominates the market for advanced chips, which it considers to be 7 nanometers (nm) or under. Those chips made up 73% of the company's revenue in the first quarter, and chips for high-performance computing, much of which is used for AI. 9. Its competition is struggling The next two largest semiconductor manufacturers are Samsung and Intel and both of those companies have faltered of late. Samsung recently apologized to investors for not innovating enough and its poor performance. Intel, meanwhile, is in the midst of a yearslong crisis. Its stock price has tumbled as the company is struggling to grow and deliver a profit. 10. It has a great track record TSMC has outperformed the S&P 500 over virtually any time frame in its history. Over the last five years, the stock is up nearly 300% and 800% over the last decade. Past performance doesn't guarantee future returns in the stock market, but winners tend to keep winning, and TSMC looks poised to do that. Should you invest $1,000 in Taiwan Semiconductor Manufacturing right now? Before you buy stock in Taiwan Semiconductor Manufacturing, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Taiwan Semiconductor Manufacturing wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $664,089!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $881,731!* Now, it's worth noting Stock Advisor 's total average return is994% — a market-crushing outperformance compared to172%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of June 9, 2025 Jeremy Bowman has positions in Advanced Micro Devices, Broadcom, Nvidia, and Taiwan Semiconductor Manufacturing. The Motley Fool has positions in and recommends Advanced Micro Devices, Apple, Intel, Microsoft, Nvidia, and Taiwan Semiconductor Manufacturing. The Motley Fool recommends Broadcom and recommends the following options: long January 2026 $395 calls on Microsoft, short August 2025 $24 calls on Intel, and short January 2026 $405 calls on Microsoft. The Motley Fool has a disclosure policy.
Globe and Mail
10 hours ago
- Globe and Mail
CanadaBis Capital With its wholly owned Sub. (STIGMA GROW) Announces Record Revenue Q1 F2025 Resulting in $9.6M Gross with $321,569 in NET Earnings and an Adjusted EBITDA of $675,892
CALGARY, AB , Dec. 31, 2024 /CNW/ - CanadaBis Capital (the "Company" or "CanadaBis Capital") (TSXV: CANB.V) a premium cannabis and concentrates producer, is pleased to announce its First Quarter Fiscal 2025 financial results for the three month period ending October 31, 2024 . "Our Brands continue to deliver products that are in demand, and our dedication towards our quality continue to prove our strength in the market.", said Travis McIntyre , CEO of CanadaBis. "While we continue to focus on profitability, we are delighted to be able to post yet another record quarter of revenue. Our product launch momentum also continues to accelerate with Multiple new products launched this quarter. We exit Q1 F2025 with our most aggressive and innovate pipeline of new products in the Company's history. Financial Highlights The Company realized its Record gross revenue of $9.6 million for October 31, 2024 , and 7% higher than the same corresponding period of 2023. The Company achieved positive net income of $321,569 for the three months ended October 31, 2024 . The Company continues to market its Resin Infused Pre-rolls, Shatter Infused Pre-rolls, Resin Infused Flower, along with Moonrocks (Moonrocks are whole flower, coated in resin and rolled in kief). The Company was able to maintain sales of its newest product line, Super Slim Cigarette Style Pre-Rolls, the Electric Dartz. These new products were packaged in 10 packs 0.4 grams per roll both infused and non infused. Adjusted EBITDA also showed positive earnings with $675,892 for the three months Stigma Grow's deep innovation sales pipeline is showcased by the consistent launch of new SKU's and new products driven by customer demand. The Company sold over 570,000 units of combined concentrate and dry flower for the three months ended October 31, 2024 , a 4% increase compared to the 550,000 units sold over the corresponding period in 2024. The Company continues to manage its input expenses through negotiation with multiple suppliers to save costs while increasing concentrate yields. The Company is in the process of shipping its first international sales to Europe . The expectation is that this would be the next significant phase of the Company's mission in growth and new geographic area of existing revenue stream for Cultivation and Wholesale. Stigma Grow also continues to re-formulate its concentrate lines to meet current clients' demands to maintain larger terpene and cannabinoid profiles across the lineup. Negotiations with other Cannabis Cultivators are ongoing by the Company which has allowed significant reduction in costs, a trend that is expected to continue through 2025 as more Cultivators reposition themselves in the industry The Company announced the launch of the latest addition to the Dab Bods brand lineup – a groundbreaking 60%+ double-infused pre-roll. This new offering sets a new benchmark for THC potency in the Canadian market. Dab bods Brand continues to grow with the demand across Cananda and is will be launching 2 new exciting products in the DAB N DIPS and the CANADAS 1st DAB N GO both products will revolutionize the way cannabis is consumed by offering discreet usage. QUARTERLY HIGHLIGHTS • Adjusted EBITDA is a Non-GAAP performance measure. Refer to "Cautionary Statement Regarding Certain Non-GAAP Performance Measures" for further details. Presenting Adjusted EBITDA only for the three and six months ended October 31, 2024. EBITDA calculation shown by entity to present the breakdown of each entity. General Overall gross revenues for the period ended October 31, 2024 increased to $9.6 million from $9.0 million in the corresponding period of 2024. This increase was due to continued growth and demand from new and existing SKUs launched under the Dab Bod Brands and the industry's demand for new innovative products such as the +60s Pre-rolls and our famous milled flower and Dartz . Net revenue of $5.1 million compared to $5.7 million for the corresponding period of 2024 or 11.74% decrease. Net Revenue for Q1 2025 of $5.1 million increased over Q4 2024 of $3.9 million by $1.2 million or 31%. The Company has experienced growth in the existing Provinces due to both new launches and the performance of existing products. The Company has released several versions of the new cigarette style pre-roll in infused and non-infused as well as the new " Dap N Go" that has been well received in the concentrate space. The Province of Manitoba has seen higher increases from our new and existing products. See Segmented Reporting section to this MD&A, for a more detailed discussion. The Company was able to initiate more cost savings initiatives during Q1 2025, through cost savings by renegotiating input material pricing while also implementing new procedures in its production lines to cut and manage operational costs. Management is of the expectation that these new initiatives will be realized throughout 2025. Given the Company's position as a vertically integrated Cannabis company/producer, management will continue to adjust internal strategy based on external factors causing fluctuations in either selling prices of products/services and input cost of products and services to ensure capacity allocation is being optimized on products/services in highest demand, while ensuring mandated gross profit margins are being achieved. Management notes that the current climate of Cannabis industry is extremely competitive and saturated with multiple products across the Nation. The Company has several competitive advantages to ensure long-term success within the industry. In the short-term, this relates primarily with respect to our butane hydrocarbon (BHO) extraction process. Management continues to explore various concentrate products to diversify it offer to the market by formulating new products to meet demand. About CanadaBis Capital Inc. CanadaBis Capital Inc. ( TSXV:CANB ) is a vertically integrated Canadian cannabis company focused on achieving large-scale growth in the global cannabis market – with specific attention paid to supplying the fast-emerging concentrates category through their Stigma Grow cultivation and BHO extraction facility. Subsidiaries: Stigma Pharmaceuticals Inc. – 100% held; 1998643 Alberta Ltd. (operating as "Stigma Grow") - 100% held; include cultivation and wholesale, extraction and tolling Full Spectrum Labs Ltd. (operating as "Stigma Roots") - 100% held; 2103157 Alberta Ltd. (operating as "INDICAtive Collection") -100% held; the retail operation, and Goldstream Cannabis Inc. - 95% held. Acting as the cornerstone for everything they offer, Stigma Grow continuously strives to address the market demands and lingering stigmas within the legal cannabis industry head-on, with products designed to disturb the status quo and dramatically shift the conversation surrounding Canada's legal cannabis industry. For more information on CanadaBis Capital or Stigma Grow visit: CAUTIONARY STATEMENT Non-GAAP Measures This news release contains the financial performance metric of Adjusted EBITDA, a measure that is not recognized or defined under IFRS (a "Non-GAAP Measure"). As a result, this data may not be comparable to data presented by other cannabis companies. For an explanation and reconciliation of Adjusted EBITDA to related comparable financial information presented in the Financial Statements prepared in accordance with IFRS, refer to the MD&A for the three and six months ended Oct 31, 2024. The Company believes that Adjusted EBITDA is a useful indicator of operational performance and is specifically used by management to assess the financial and operational performance of the Company. Adjusted EBITDA is a measure of the Company's financial performance. It is intended to provide a proxy for the Company's operating cash flow and is widely used by industry analysts to compare CanadaBis to its competitors and derive expectations of future financial performance of the Company. Adjusted EBITDA increases comparability between comparative companies by eliminating variability resulting from differences in capital structures, management decisions related to resource allocation, and the impact of fair value adjustments on biological assets, inventory, and financial instruments, which may be volatile on a period-to-period basis. Adjusted EBTIDA is not a recognized, defined, or standardized measure under IFRS. The Company calculates Adjusted EBITDA as net income (loss) and comprehensive income (loss) excluding changes in fair value of biological assets, change in fair value of biological assets realized through inventory sold, depreciation and amortization expense, share-based payments, and finance costs. REGARDING FORWARD-LOOKING INFORMATION: This news release includes certain "forward-looking statements" under applicable Canadian securities legislation. Forward-looking statements include but are not limited to statements with respect to our business and operations; timing of the Sundial products coming to market; the demand and market for live-resin vape cartridges, and our general business plans. Forward-looking statements are necessarily based upon a number of assumptions including: the ability of the Company's products to compete with the pricing and product availability on the black-market; the market demand for the Company's products; and assumptions concerning the Company's competitive advantages. These assumptions, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: compliance with extensive government regulation, the general business, economic, competitive, political and social uncertainties; ability to sustain or create a demand for a product; requirement for further capital; delay or failure to receive board, shareholder or regulatory approvals; the results of operations and such other matters as set out in the Company's continuous disclosure on SEDAR at There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. Investors are cautioned that forward-looking information is not based on historical facts but instead reflects management's expectations, estimates or projections concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although we believe that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have a material adverse effect on our future results, performance or achievements. Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although the Company has attempted to identify important risks, uncertainties and factors which could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. The Company does not intend, and does not assume any obligation, to update this forward-looking information except as otherwise required by applicable law.
